HK Stock MarketDetailed Quotes

01618 MCC

Watchlist
  • 1.550
  • +0.030+1.97%
Not Open May 6 16:08 CST
32.12BMarket Cap3.65P/E (TTM)

MCC Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Turnover
3.81%149.95B
6.95%633.87B
17.70%467.32B
15.65%334.46B
22.39%144.45B
18.40%592.67B
13.61%397.04B
15.22%289.2B
25.00%118.03B
25.11%500.57B
Operating income
3.81%149.95B
6.95%633.87B
17.70%467.32B
15.65%334.46B
22.39%144.45B
18.40%592.67B
13.61%397.04B
15.22%289.2B
25.00%118.03B
25.11%500.57B
Operating expenses
-5.25%-137.67B
-6.90%-572.46B
-18.21%-424.22B
-15.74%-303.47B
-23.84%-130.81B
-19.69%-535.52B
-14.04%-358.87B
-15.73%-262.19B
-26.32%-105.63B
-26.15%-447.44B
Gross profit
-10.04%12.27B
7.46%61.41B
12.92%43.11B
14.72%30.99B
10.05%13.64B
7.56%57.15B
9.66%38.18B
10.49%27.01B
14.78%12.4B
16.97%53.14B
Selling expenses
-6.35%-699.61M
-9.93%-3.17B
-14.71%-2.01B
-13.42%-1.39B
-10.80%-657.85M
-5.12%-2.88B
-0.16%-1.76B
-6.19%-1.23B
-8.42%-593.74M
-12.35%-2.74B
Administrative expenses
-3.76%-3.19B
-9.64%-12.36B
-10.94%-8.08B
-9.83%-5.43B
-10.56%-3.07B
-3.22%-11.27B
-0.40%-7.29B
2.02%-4.94B
-1.64%-2.78B
0.81%-10.92B
Research and development expenses
-0.11%-2.82B
-5.33%-19.73B
-15.76%-13.54B
-18.99%-9.09B
-7.14%-2.81B
-17.81%-18.73B
-17.88%-11.69B
-27.13%-7.64B
-54.55%-2.63B
-29.00%-15.9B
Profit from asset sales
832.47%147.71M
118.58%663.08M
-77.69%51.26M
-67.28%33.96M
117.27%15.84M
-55.99%303.36M
-47.48%229.74M
-75.74%103.78M
-10.24%7.29M
195.93%689.23M
Revaluation surplus
-5,553.63%-183.86M
1.12%-314.22M
-10.35%-458.64M
-151.26%-328.38M
-140.28%-3.25M
-278.59%-317.78M
-604.71%-415.61M
-353.88%-130.7M
-25.85%8.07M
426.07%177.93M
-Changes in the fair value of other assets
-5,553.63%-183.86M
1.12%-314.22M
-10.35%-458.64M
-151.26%-328.38M
-140.28%-3.25M
-278.59%-317.78M
-604.71%-415.61M
-353.88%-130.7M
-25.85%8.07M
426.07%177.93M
Impairment and provision
-0.46%-915.76M
-80.37%-8.95B
-0.78%-4.01B
-5.58%-3.08B
-7.47%-911.58M
7.07%-4.96B
-25.11%-3.98B
-38.32%-2.92B
-22.29%-848.22M
-45.09%-5.34B
-Other impairment is provision
-0.46%-915.76M
-80.37%-8.95B
-0.78%-4.01B
-5.58%-3.08B
-7.47%-911.58M
7.07%-4.96B
-25.11%-3.98B
-38.32%-2.92B
-22.29%-848.22M
-45.09%-5.34B
Special items of operating profit
37.38%-150.35M
14.93%-927.25M
44.19%-512.87M
19.45%-506.66M
-85.71%-240.12M
20.17%-1.09B
-673.91%-919.01M
-18.17%-628.99M
-38.01%-129.3M
-98.44%-1.37B
Operating profit
-25.39%4.1B
-9.93%14.7B
21.42%13.17B
17.01%10.2B
8.29%5.49B
7.28%16.33B
-7.00%10.85B
-2.56%8.72B
15.90%5.07B
12.06%15.22B
Financing cost
-16.02%-222.82M
-5.13%-989.12M
-1,280.18%-516.54M
-127.33%-248.6M
36.71%-192.05M
10.83%-940.84M
103.55%43.77M
89.69%-109.36M
24.84%-303.44M
40.30%-1.06B
Special items of earning before tax
-55.61%13.14M
576.18%48.94M
24.10%29.08M
-249.57%-56.18M
24.14%29.6M
104.81%7.24M
-85.00%23.44M
-73.48%37.56M
-70.63%23.84M
-244.21%-150.34M
Earning before tax
-27.05%3.89B
-10.57%13.76B
16.21%12.69B
14.46%9.9B
11.22%5.33B
9.85%15.39B
3.09%10.92B
7.69%8.65B
18.22%4.79B
17.58%14.01B
Tax
21.02%-743.95M
4.14%-2.36B
-10.81%-2.19B
5.60%-1.22B
5.76%-941.91M
-2.31%-2.46B
4.18%-1.97B
10.28%-1.29B
1.63%-999.49M
5.13%-2.4B
After-tax profit from continuing operations
-28.34%3.14B
-11.80%11.41B
17.40%10.5B
17.98%8.68B
15.69%4.39B
11.41%12.93B
4.85%8.94B
11.62%7.36B
24.87%3.79B
23.71%11.61B
Earning after tax
-28.34%3.14B
-11.80%11.41B
17.40%10.5B
17.98%8.68B
15.69%4.39B
11.41%12.93B
4.85%8.94B
11.62%7.36B
24.87%3.79B
23.71%11.61B
Minority profit
-54.16%466.2M
3.02%2.74B
3.74%2.32B
-1.50%1.46B
-8.58%1.02B
-17.84%2.66B
-7.07%2.23B
-10.27%1.48B
23.46%1.11B
112.62%3.23B
Profit attributable to shareholders
-20.56%2.68B
-15.63%8.67B
21.94%8.18B
22.90%7.22B
25.77%3.37B
22.70%10.28B
9.52%6.71B
18.95%5.87B
25.46%2.68B
6.52%8.37B
Basic earnings per share
-20.00%0.12
-26.67%0.33
10.71%0.31
8.33%0.26
25.00%0.15
28.57%0.45
7.69%0.28
14.29%0.24
20.00%0.12
9.37%0.35
Diluted earnings per share
-20.00%0.12
-26.67%0.33
10.71%0.31
8.33%0.26
25.00%0.15
28.57%0.45
7.69%0.28
14.29%0.24
0.12
0.35
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
Auditor
--
Ernst & Young (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
--
--
--
Daishin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Turnover 3.81%149.95B6.95%633.87B17.70%467.32B15.65%334.46B22.39%144.45B18.40%592.67B13.61%397.04B15.22%289.2B25.00%118.03B25.11%500.57B
Operating income 3.81%149.95B6.95%633.87B17.70%467.32B15.65%334.46B22.39%144.45B18.40%592.67B13.61%397.04B15.22%289.2B25.00%118.03B25.11%500.57B
Operating expenses -5.25%-137.67B-6.90%-572.46B-18.21%-424.22B-15.74%-303.47B-23.84%-130.81B-19.69%-535.52B-14.04%-358.87B-15.73%-262.19B-26.32%-105.63B-26.15%-447.44B
Gross profit -10.04%12.27B7.46%61.41B12.92%43.11B14.72%30.99B10.05%13.64B7.56%57.15B9.66%38.18B10.49%27.01B14.78%12.4B16.97%53.14B
Selling expenses -6.35%-699.61M-9.93%-3.17B-14.71%-2.01B-13.42%-1.39B-10.80%-657.85M-5.12%-2.88B-0.16%-1.76B-6.19%-1.23B-8.42%-593.74M-12.35%-2.74B
Administrative expenses -3.76%-3.19B-9.64%-12.36B-10.94%-8.08B-9.83%-5.43B-10.56%-3.07B-3.22%-11.27B-0.40%-7.29B2.02%-4.94B-1.64%-2.78B0.81%-10.92B
Research and development expenses -0.11%-2.82B-5.33%-19.73B-15.76%-13.54B-18.99%-9.09B-7.14%-2.81B-17.81%-18.73B-17.88%-11.69B-27.13%-7.64B-54.55%-2.63B-29.00%-15.9B
Profit from asset sales 832.47%147.71M118.58%663.08M-77.69%51.26M-67.28%33.96M117.27%15.84M-55.99%303.36M-47.48%229.74M-75.74%103.78M-10.24%7.29M195.93%689.23M
Revaluation surplus -5,553.63%-183.86M1.12%-314.22M-10.35%-458.64M-151.26%-328.38M-140.28%-3.25M-278.59%-317.78M-604.71%-415.61M-353.88%-130.7M-25.85%8.07M426.07%177.93M
-Changes in the fair value of other assets -5,553.63%-183.86M1.12%-314.22M-10.35%-458.64M-151.26%-328.38M-140.28%-3.25M-278.59%-317.78M-604.71%-415.61M-353.88%-130.7M-25.85%8.07M426.07%177.93M
Impairment and provision -0.46%-915.76M-80.37%-8.95B-0.78%-4.01B-5.58%-3.08B-7.47%-911.58M7.07%-4.96B-25.11%-3.98B-38.32%-2.92B-22.29%-848.22M-45.09%-5.34B
-Other impairment is provision -0.46%-915.76M-80.37%-8.95B-0.78%-4.01B-5.58%-3.08B-7.47%-911.58M7.07%-4.96B-25.11%-3.98B-38.32%-2.92B-22.29%-848.22M-45.09%-5.34B
Special items of operating profit 37.38%-150.35M14.93%-927.25M44.19%-512.87M19.45%-506.66M-85.71%-240.12M20.17%-1.09B-673.91%-919.01M-18.17%-628.99M-38.01%-129.3M-98.44%-1.37B
Operating profit -25.39%4.1B-9.93%14.7B21.42%13.17B17.01%10.2B8.29%5.49B7.28%16.33B-7.00%10.85B-2.56%8.72B15.90%5.07B12.06%15.22B
Financing cost -16.02%-222.82M-5.13%-989.12M-1,280.18%-516.54M-127.33%-248.6M36.71%-192.05M10.83%-940.84M103.55%43.77M89.69%-109.36M24.84%-303.44M40.30%-1.06B
Special items of earning before tax -55.61%13.14M576.18%48.94M24.10%29.08M-249.57%-56.18M24.14%29.6M104.81%7.24M-85.00%23.44M-73.48%37.56M-70.63%23.84M-244.21%-150.34M
Earning before tax -27.05%3.89B-10.57%13.76B16.21%12.69B14.46%9.9B11.22%5.33B9.85%15.39B3.09%10.92B7.69%8.65B18.22%4.79B17.58%14.01B
Tax 21.02%-743.95M4.14%-2.36B-10.81%-2.19B5.60%-1.22B5.76%-941.91M-2.31%-2.46B4.18%-1.97B10.28%-1.29B1.63%-999.49M5.13%-2.4B
After-tax profit from continuing operations -28.34%3.14B-11.80%11.41B17.40%10.5B17.98%8.68B15.69%4.39B11.41%12.93B4.85%8.94B11.62%7.36B24.87%3.79B23.71%11.61B
Earning after tax -28.34%3.14B-11.80%11.41B17.40%10.5B17.98%8.68B15.69%4.39B11.41%12.93B4.85%8.94B11.62%7.36B24.87%3.79B23.71%11.61B
Minority profit -54.16%466.2M3.02%2.74B3.74%2.32B-1.50%1.46B-8.58%1.02B-17.84%2.66B-7.07%2.23B-10.27%1.48B23.46%1.11B112.62%3.23B
Profit attributable to shareholders -20.56%2.68B-15.63%8.67B21.94%8.18B22.90%7.22B25.77%3.37B22.70%10.28B9.52%6.71B18.95%5.87B25.46%2.68B6.52%8.37B
Basic earnings per share -20.00%0.12-26.67%0.3310.71%0.318.33%0.2625.00%0.1528.57%0.457.69%0.2814.29%0.2420.00%0.129.37%0.35
Diluted earnings per share -20.00%0.12-26.67%0.3310.71%0.318.33%0.2625.00%0.1528.57%0.457.69%0.2814.29%0.240.120.35
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified Opinion------Unqualified Opinion------Unqualified Opinion
Auditor --Ernst & Young (Special General Partnership)------Ernst & Young (Special General Partnership)------Daishin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg